Do Arginine and Citrulline Cross the Blood-Brain Barrier? What Actually Reaches the Brain
Arginine crosses the blood-brain barrier via cationic amino acid transporters, and citrulline crosses via neutral transporters, but transport is competitive and tightly regulated. MemoHoney's mechanism does not depend on brain entry: the nitric oxide effect happens in the endothelial cells of blood vessels, including cerebral vessels, from the blood side. Brain perfusion, not neuronal uptake, is the relevant pathway.
- Arginine: CAT-1 transporter
- Citrulline: LAT transporters
- Competitive, saturable transport
- Vascular effect needs no brain entry
How amino acids get into the brain
The blood-brain barrier is not a wall but a set of selective transporters. Arginine enters through cationic amino acid transporter 1 (CAT-1), competing with lysine and ornithine. Citrulline, a neutral amino acid, uses the large neutral amino acid transporters shared with tryptophan, tyrosine and the branched-chain amino acids. Both systems are saturable: raising one amino acid's blood level increases its uptake only until the transporter is busy, and can reduce uptake of its competitors.
What arginine does once inside
Neurons contain their own nitric oxide synthase (nNOS), and nitric oxide is a genuine neurotransmitter involved in learning and blood-flow coupling. Brain arginine, however, is largely supplied by astrocytes recycling citrulline back to arginine locally, and intracellular concentrations are already high. There is little evidence that raising blood arginine changes neuronal nitric oxide signalling in healthy people. The brain is not the limiting compartment.
The vascular route is the mechanism
The cerebral arteries and the capillary network are lined with endothelial cells facing the blood. Arginine and citrulline in the bloodstream reach those cells directly, without crossing the barrier. Nitric oxide made there relaxes cerebral vessels and supports perfusion — which is the whole logic of a circulation-first brain supplement. Whether any precursor enters the brain parenchyma is beside the point for MemoHoney's claimed mechanism.
Reading brain claims correctly
When a product says it "nourishes brain cells", ask whether the ingredient needs to enter the brain to do what is claimed. For nitric oxide precursors, it does not; the claim should be about perfusion. For nutrients like niacin, entry matters and is well handled by dedicated transporters. For calcium, the barrier deliberately insulates the brain from dietary swings. Sorting claims this way removes most of the marketing fog.
What this means for MemoHoney
MemoHoney's arginine and citrulline are meant to work on the vessel side of the barrier, supporting the blood supply that reaches the brain. That is a coherent mechanism at any dose; the modest amounts determine how much it does, not whether it applies.
| Ingredient | Per capsule | Research / RDA range |
|---|---|---|
| Niacin (Vitamin B3) | 7.5 mg NE | 14–16 mg NE (RDA) |
| Calcium | 18 mg | 1,000–1,200 mg (RDA) |
| L-Arginine (base) | 200 mg | 3,000–6,000 mg |
| L-Arginine AKG 2:1 | 200 mg | 3,000–6,000 mg |
| L-Citrulline HCl | 100 mg | 3,000–8,000 mg |
| L-Citrulline Malate | 100 mg | 3,000–8,000 mg |
| Beta-Alanine | 40 mg | 2,000–6,000 mg |
Every MemoHoney amount is printed on the label — no proprietary blend. Full analysis on the ingredients page; mechanism on how it works.
Key takeaways
- Both amino acids can cross the barrier, but that is not the mechanism.
- Nitric oxide is made in vessel walls from the blood side.
- Judge MemoHoney as a perfusion supplement, not a neuronal one.
FAQ
Not in healthy adults — neuronal arginine is locally recycled and not blood-limited. Vascular nitric oxide is the realistic target.
In principle, large neutral amino acids compete with tryptophan at the barrier. At 200 mg of citrulline the effect is negligible.
Cerebral vessels have strong autoregulation, so nitric oxide effects are moderated. Systemic and cerebral responses are related but not identical.